Most recent filing notes his use of Donegal holdings as collateral for a $2.5M note. Wonder why an SEC filing was necessary for this??
8/21/15 Thomson Reuters report shows new mean price target of $0.85 (up from $0.65), but FY15 est. deps cut in half from $0.04 to $0.02. Not sure when report was issued, but it seems like old news judging from Friday's stock price.
for several weeks after falling below the $1.50 price target, fsi's lone analyst continued to have a mean "reduce" recommendation. finally changed that to a "buy" this week while increasing fy15 est by a penny.
Apparently not a new innovation as the LA water department is reported to have used the "shade balls" as early as 2008. Also, LA's application appears to be for its treated water [concrete-bottomed reservoirs] that otherwise would have needed to be completely covered (at a cost of $300M) in order to comply with Safe Drinking Water Act. This may partly explain why it was willing to spend about ten times more for the same amount of water savings compared to FSI's product.
unless current price drop reflects shepard unloading shares that has not yet been reflected in sec filings, he still owns 3.675M A shares and 400k B shares
like lending tree relationship as well as new financing arrangements, key hires, office space expansion, all of which point to continued growth, but not sure of impact company's possible intention to raise additional capital through share sale after special dividend is paid
maybe on the 24th. possibly available from broker?? although positive, 2 analysts rate at "Hold", with no price target reported (as of yet). fy15 est deps=$0.04.
wasn't that something to be voted on? $1MM for a 12+% stake in medical sub may seem cheap in light of apparent recent strong expressions of interest by other parties reported by ceo. other than relationship with climaco, etc., why jump in to an agreement of that nature NOW when company has said that funding not a major issue at this stage?